Page last updated: 2024-10-25

deferiprone and Coma

deferiprone has been researched along with Coma in 1 studies

Deferiprone: A pyridone derivative and iron chelator that is used in the treatment of IRON OVERLOAD in patients with THALASSEMIA.
deferiprone : A member of the class of 4-pyridones that is pyridin-4(1H)-one substituted at positions 1 and 2 by methyl groups and at position 3 by a hydroxy group. A lipid-soluble iron-chelator used for treatment of thalassaemia.

Coma: A profound state of unconsciousness associated with depressed cerebral activity from which the individual cannot be aroused. Coma generally occurs when there is dysfunction or injury involving both cerebral hemispheres or the brain stem RETICULAR FORMATION.

Research Excerpts

ExcerptRelevanceReference
"Deferiprone (L1) seems to be a promising agent as an adjuvant in the treatment for severe P."6.70Deferiprone (L1) as an adjuvant therapy for Plasmodium falciparum malaria. ( Ghosh, K; Karnad, D; Mohanty, D; Pathare, AV, 2002)
"Deferiprone (L1) seems to be a promising agent as an adjuvant in the treatment for severe P."2.70Deferiprone (L1) as an adjuvant therapy for Plasmodium falciparum malaria. ( Ghosh, K; Karnad, D; Mohanty, D; Pathare, AV, 2002)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mohanty, D1
Ghosh, K1
Pathare, AV1
Karnad, D1

Trials

1 trial available for deferiprone and Coma

ArticleYear
Deferiprone (L1) as an adjuvant therapy for Plasmodium falciparum malaria.
    The Indian journal of medical research, 2002, Volume: 115

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Antimalarials; Coma; Deferiprone; Double-Blind

2002